Health - Jul 16
FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101)
FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101)
Pharmacology - Jul 11
Novartis, Amgen and Banner Alzheimer’s Institute discontinue clinical program with BACE inhibitor CNP520 for Alzheimer’s prevention
Novartis, Amgen and Banner Alzheimer’s Institute discontinue clinical program with BACE inhibitor CNP520 for Alzheimer’s prevention
medicine and life sciences
Life Sciences - Jul 21
The Friedrich Miescher Institute for Biomedical Research is a leader in the field of DNA and RNA research. DNA has become the icon of modern bioscience but few people realize that it was our namegiver, who - almost a century before Watson and Crick - laid the chemical groundwork for the molecular breakthroughs that followed.
Health - Jul 17
Acute myeloid leukemia stem cells elude the body's immune cells by deactivating a danger detector.
Music - Jul 17
Researchers at UNIGE and at Maastricht University have demonstrated that the brain adapts to a person's listening intentions by focusing either on a speaker's voice or on the speech sounds that are being uttered.
Selected Jobs
Health - 05.07
Lehrbeauftragte / Lehrbeauftragter im Bereich Medizintechnik 20% Hochschule Luzern, Horw/Luzern
Lehrbeauftragte / Lehrbeauftragter im Bereich Medizintechnik 20% Hochschule Luzern, Horw/Luzern
Health - 14.06
Professeur-e HES associé-e - Enseignement dans le domaine des sciences humaines HES-SO Genève
Professeur-e HES associé-e - Enseignement dans le domaine des sciences humaines HES-SO Genève
Health - 19.07
PhD Candidate - Marie-Sklodowska Curie programme Community care Double doctoral degree, University of Basel (CH) -, University... University of Basel
PhD Candidate - Marie-Sklodowska Curie programme Community care Double doctoral degree, University of Basel (CH) -, University... University of Basel
Health - 19.07
PhD Candidate position in Lab ’Translational Diabetes’ Department of Biomedicine / 100% University of Basel
PhD Candidate position in Lab ’Translational Diabetes’ Department of Biomedicine / 100% University of Basel
Employers of the Week
Continuing education for scientists and academics
»» 31.07.2019
MAS ETH Mediation in Peace Processes (MAS ETH MPP) Eidgenossische Technische Hochschule Zürich, ETHZ
MAS ETH Mediation in Peace Processes (MAS ETH MPP) Eidgenossische Technische Hochschule Zürich, ETHZ
»» 30.09.2019
CAS ETH in Räumliche Informationssysteme (CAS ETH RIS) Eidgenossische Technische Hochschule Zürich, ETHZ
CAS ETH in Räumliche Informationssysteme (CAS ETH RIS) Eidgenossische Technische Hochschule Zürich, ETHZ
»» 01.11.2019
MAS ETH in Applied Technology (MAS ETH AT) Eidgenossische Technische Hochschule Zürich, ETHZ
MAS ETH in Applied Technology (MAS ETH AT) Eidgenossische Technische Hochschule Zürich, ETHZ
Last job offers
- Psychology - 18.7
zwei Doktoranden / Doktorandinnen Psychologie - Innovation/Technology - 17.7
Studiengangleiter*in und Dozent*in Digital Engineering (80-100%) - Health - 17.7
Dozent/in im Bereich Medizintechnik 80 - 100% - Environment - 17.7
Assistentin /Assistent Waldpolitik (80-100%) - Art and Design - 17.7
Wissenschaftliche/r Assistent/in Atelier- und Werkstattbetreuung (30 %) - Electroengineering - 17.7
Dozentin / Dozent für Mikroprozessortechnik / Embedded Systems (100%) - Computer Science/Telecom - 17.7
Dozentin / Dozent mit Schwerpunkt Open Data in den Anwendungsgebieten Mobilität / Tourismus (80-100%) - Chemistry - 17.7
Wissenschaftliche/r Assistent/in Anorganische Analytische Chemie (100%)
Health - Jul 16
FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101)
FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101)
Pharmacology - Jul 11
Novartis, Amgen and Banner Alzheimer’s Institute discontinue clinical program with BACE inhibitor CNP520 for Alzheimer’s prevention
Novartis, Amgen and Banner Alzheimer’s Institute discontinue clinical program with BACE inhibitor CNP520 for Alzheimer’s prevention